Carmen Castrillo‐Viguera

Clinical significance in the change of decline in ALSFRS-R

Carmen Castrillo‐Viguera, Daniela Grasso, Elizabeth Simpson et al. · Amyotrophic Lateral Sclerosis · 2010 · 123 citations

Medicine, Neurology, Neuroscience +15

Optimal Intereye Difference Thresholds in Retinal Nerve Fiber Layer Thickness for Predicting a Unilateral Optic Nerve Lesion in Multiple Sclerosis

Rachel Nolan, Steven Galetta, Teresa C. Frohman et al. · Journal of Neuro-Ophthalmology · 2018 · 60 citations · Full text

Medicine, Neurology, Ophthalmology +17

Alzheimer disease neuropathology in a patient previously treated with aducanumab

Edward D. Plowey, Thierry Bussière, Raj Rajagovindan et al. · Acta Neuropathologica · 2022 · 53 citations · Full text

Medicine, Neurology, Pharmacotherapy +17

Genome-Wide Association Studies of ARIA From the Aducanumab Phase 3 ENGAGE and EMERGE Studies

Stephanie Loomis, Ryan Miller, Carmen Castrillo‐Viguera et al. · Neurology · 2023 · 38 citations · Full text

Life Sciences, Genetics, Neurology +8

Results from the long‐term extension of PRIME: A randomized Phase 1b trial of aducanumab

Tianle Chen, John O’Gorman, Carmen Castrillo‐Viguera et al. · Alzheimer s & Dementia · 2024 · 30 citations · Full text

Medicine, Neurology, Pharmacology +17